Single award · contract
Contract 75A50122C00076
Award ID: 75A50122C00076
FY2022 · complete year · data as of 2026-07-11
A single federal award, with both ends of the trail linked.
$155.2M
Total award value
Award 75A50122C00076 is a contract from the Department of Health and Human Services, $155.2M obligated, FY2022 to FY2033. The work is performed in California. It is classified as NAICS 541714 (Research and Development in Biotechnology (except Nanobiotechnology)) and PSC AN13 (Health R&D Services; Health Care Services; Experimental Development). Source
Description
This Cost-Plus-Fixed-Fee Contract with Mapp Biopharmaceutical, Inc. (Mapp or Contractor) Is for the Development of Mapp?s Therapeutic Intervention MBP091, as an Immunotherapy for the Treatment of Marburg Virus Infection.
Award details
Award typeContract
PIID75A50122C00076
Action date2022
Period123 mo
Awarding agencyDepartment of Health and Human Services →
RecipientOutside our Phase 1 contractor set: see methodology
Place of performanceCalifornia →
CategoryNAICS 541714PSC AN13
Competed?Not recordedSource
Total (exact)$155,212,688
More from Department of Health and Human Services
awarded 2025$110.4B
awarded 2024$100.1B
awarded 2023$92B
awarded 2022$80.5B
awarded 2021$80.5B
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.